Seminar Shows Continued Divergence Among Nations On Regulating Internet 14/02/2014 by Maëli Astruc for Intellectual Property Watch 1 Comment It is generally considered that internet governance and cyber safety issues should be addressed in a multilateral way, but several points remain highly controversial, such as the adoption of rules and modifications of internet governance to be made. These issues were the subject of a panel at the UN Institute for Disarmament Research this week.
South Africa Promotion And Protection Of Investment Bill 2013 – A Review 13/02/2014 by Intellectual Property Watch 2 Comments On 1 November 2013, the South African Department of Trade and Industry published the draft “Promotion and Protection of Investment Bill” for comments. And two lawyers caution that if not careful, it could come in conflict with the country’s international intellectual property obligations.
Biopharma Industries, Others Urge Caution In US Patent Reform 12/02/2014 by William New, Intellectual Property Watch Leave a Comment A coalition of large and small companies and organisation – including the leading trade associations for the US pharmaceutical and biotechnology industries – has asked the US Congress to use caution in rewriting patent laws so as not to cause unintended harm to their ability to innovate.
WHO, IFRC Tap Swiss Federal Funds For New Buildings 12/02/2014 by Intellectual Property Watch Leave a Comment The World Health Organization and International Federation of the Red Cross and Red Crescent have received approval of the Swiss Federal Council to receive millions of Swiss francs in loans for the purpose of planning new buildings in Geneva.
EU Commission Pushes Internationalisation Of Core Internet Infrastructure 12/02/2014 by Monika Ermert for Intellectual Property Watch Leave a Comment Over the revelations of mass surveillance of internet users and government officials, the topic of internet governance has risen to the mainstream political agenda. And a Communication on “Europe’s role in shaping the future of Internet Governance” passed by the European Commission today would put “Europe in the center of the debate,” EC Vice President Neelie Kroes said in a press conference in Brussels.
USTR Announces “Notorious” Markets For Counterfeiting, Piracy In 2013 12/02/2014 by William New, Intellectual Property Watch 2 Comments The Office of the United States Trade Representative today published its annual list of online and physical marketplaces worldwide that are most engaged in sales and trafficking of counterfeit and pirated goods.
Interviews With The Candidates For WIPO Director General 12/02/2014 by William New, Intellectual Property Watch 4 Comments Member states of the UN World Intellectual Property Organization, the global body for international IP policy issues, will vote on 6 March for the next WIPO director general for six years. Intellectual Property Watch asked the candidates four key questions. Here are their responses.
DNDi Director: ‘Reality Check’ Needed For Neglected Diseases 11/02/2014 by Intellectual Property Watch 2 Comments Research and development into neglected diseases – those predominately affecting poorer populations and for which there is little commercial incentive – is undergoing “remarkable advances and rude set-backs,” says Bernard Pécoul, executive director of the Drugs for Neglected Diseases initiative (DNDi). Now, governments need to show stronger leadership in bringing about long-term solutions, he said.
Alert: Pharma IPR 2014 Conference In Mumbai, 26-28 February 10/02/2014 by Intellectual Property Watch Leave a Comment Dear Subscribers, CPhI’s 3rd Annual Pharma IPR 2014 conference to take place from 26-28 February, 2014 in Mumbai, India will have techno-legal experts from over 10+ regions speaking on the recent case studies on global Pharma and Biopharma patent laws. Among them, Jeffery Alan Hovden, Partner, Robins, Kaplan, Miller & Ciresi LLP from US will be speaking on critical developments in US pharma patent law in the year 2013 which have affected pharma and biopharma industry. He will also share best strategies on how Indian generic-drug and biologics enterprises need to go forward with their US-related projects. Some of the critical concerns he is planning to address include: Which pharmaceutical and diagnostic compounds and processes can even obtain a US patent? Whether the new, cheap and fast patent-challenge procedures are right for Indian companies in the life-sciences area? How to avoid paying the attorney fees for the other side in US litigation and indeed, how an Indian company might turn the tables and have the other side pay the company’s attorney fees? You can view his insights on “US Patent Law in 2013: Winds of Change” by clicking here. To optimise interactions with the audience, he and other global techno-legal experts would also be available in query handling sessions as well as one-on-one meetings, to discuss your concerns related to the US patent system. Click here to go through the detailed programme agenda. You can read more about the conference speakers here. To be a part of this exclusive event, please contact the organisers at +91 (22) 6172 7001 / conferences-india@ubm.com, or register online and take advantage of the special offers for you as you are our subscribers. P.S. You may find one of his earlier presentations on “From Small to Big: Some useful points in the coming shift from customary drugs to biologics” interesting – View the presentation here
WIPO Genetic Resources Text Compiles Differences, Heads To General Assembly 10/02/2014 by Catherine Saez, Intellectual Property Watch 3 Comments Despite spending a week in mostly closed, informal discussions, the World Intellectual Property Organization committee working on the protection of genetic resources, got little closer to breaching the opposing viewpoints. Members managed to produce a draft text – with signs of steps toward a middle ground – that they say can serve as a basis for further discussion on the development of an international instrument preventing wrongful patents.